Who
Ipek Erdogan-Trinkaus
Chief Commercial Officer
Company insider
Files Form 4 as: Chief Commercial Officer, Eton Pharmaceuticals.
In numbers
- Trades disclosed
- 7
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 12 Dec 2025
- Last trade
- 31 Jul 2026
- Last filed
- 4 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 31 Jul 2026filed 4 Aug 2026 | ETON Eton Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 31 Jul 2026filed 4 Aug 2026 | ETON Eton Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 12 Jan 2026filed 14 Jan 2026 | ETON Eton Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —40,655 at $0.00 | filing |
| 12 Jan 2026filed 14 Jan 2026 | ETON Eton Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —25,856 at $0.00 | filing |
| 12 Jan 2026filed 14 Jan 2026 | ETON Eton Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —40,655 at $0.00 | filing |
| 12 Jan 2026filed 14 Jan 2026 | ETON Eton Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —25,856 at $0.00 | filing |
| 12 Dec 2025filed 12 Dec 2025 | ETON Eton PharmaceuticalsPharmaceuticals | SEC FORM 4 Code F | $1,43785 at $16.90 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.